Correction to: Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study
- PMID: 40037367
- PMCID: PMC12010154
- DOI: 10.1093/jbmr/zjaf031
Correction to: Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study
Erratum for
-
Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study.J Bone Miner Res. 2024 Sep 2;39(9):1215-1228. doi: 10.1093/jbmr/zjae112. J Bone Miner Res. 2024. PMID: 39012717 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
